Cargando…

Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma

BACKGROUND: Sinonasal adenoid cystic carcinoma is a rare malignancy of the head and neck. Cavernous sinus invasion from sinonasal adenoid cystic carcinoma and its related management have rarely been investigated. This study evaluated the relationship between treatment outcome and cavernous sinus inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yi-Chan, Lee, Ta-Jen, Tsang, Ngan-Ming, Huang, Yenlin, Hsu, Cheng-Lung, Hsin, Li-Jen, Lee, Yi-Hsuan, Chang, Kai-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800036/
https://www.ncbi.nlm.nih.gov/pubmed/29402308
http://dx.doi.org/10.1186/s40463-018-0257-z
_version_ 1783298125074530304
author Lee, Yi-Chan
Lee, Ta-Jen
Tsang, Ngan-Ming
Huang, Yenlin
Hsu, Cheng-Lung
Hsin, Li-Jen
Lee, Yi-Hsuan
Chang, Kai-Ping
author_facet Lee, Yi-Chan
Lee, Ta-Jen
Tsang, Ngan-Ming
Huang, Yenlin
Hsu, Cheng-Lung
Hsin, Li-Jen
Lee, Yi-Hsuan
Chang, Kai-Ping
author_sort Lee, Yi-Chan
collection PubMed
description BACKGROUND: Sinonasal adenoid cystic carcinoma is a rare malignancy of the head and neck. Cavernous sinus invasion from sinonasal adenoid cystic carcinoma and its related management have rarely been investigated. This study evaluated the relationship between treatment outcome and cavernous sinus involvement in addition to other parameters. METHODS: A retrospective case series study was conducted at a tertiary referral center. The medical records of 47 patients diagnosed with primary sinonasal adenoid cystic carcinoma between 1984 and 2015 were retrospectively reviewed. The survival impact of the primary treatment modalities and the anatomic sites of tumor involvement were analyzed. RESULTS: Cavernous sinus invasion was observed in 8 patients (17%), of whom 7 had ACC tumors originating from the maxillary sinus. The results of univariate analysis revealed that tumor stage, primary surgery, and the absence of skull-base and infratemporal fossa invasion were associated with better overall survival (P = 0.033, P = 0.012, P = 0.011, and P = 0.040, respectively) and better disease-free survival (P = 0.019, P = 0.001, P = 0.017, and P = 0.029, respectively). Multivariate analysis identified primary surgery as the only independent prognostic factor for disease-free survival (P = 0.026). Cavernous sinus invasion by sinonasal adenoid cystic carcinoma was not associated with worse overall survival or disease-free survival (P = 0.200 and P = 0.198, respectively). CONCLUSIONS: Because maxillary adenoid cystic carcinoma is associated with a higher rate of cavernous sinus invasion, such cases warrant caution during preoperative planning. Primary surgery as the initial therapy provides better locoregional control and survival for patients with sinonasal adenoid cystic carcinoma. Cavernous sinus invasion did not significantly impact survival; thus, it should not be regarded as a contraindication for curative treatment.
format Online
Article
Text
id pubmed-5800036
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58000362018-02-13 Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma Lee, Yi-Chan Lee, Ta-Jen Tsang, Ngan-Ming Huang, Yenlin Hsu, Cheng-Lung Hsin, Li-Jen Lee, Yi-Hsuan Chang, Kai-Ping J Otolaryngol Head Neck Surg Original Research Article BACKGROUND: Sinonasal adenoid cystic carcinoma is a rare malignancy of the head and neck. Cavernous sinus invasion from sinonasal adenoid cystic carcinoma and its related management have rarely been investigated. This study evaluated the relationship between treatment outcome and cavernous sinus involvement in addition to other parameters. METHODS: A retrospective case series study was conducted at a tertiary referral center. The medical records of 47 patients diagnosed with primary sinonasal adenoid cystic carcinoma between 1984 and 2015 were retrospectively reviewed. The survival impact of the primary treatment modalities and the anatomic sites of tumor involvement were analyzed. RESULTS: Cavernous sinus invasion was observed in 8 patients (17%), of whom 7 had ACC tumors originating from the maxillary sinus. The results of univariate analysis revealed that tumor stage, primary surgery, and the absence of skull-base and infratemporal fossa invasion were associated with better overall survival (P = 0.033, P = 0.012, P = 0.011, and P = 0.040, respectively) and better disease-free survival (P = 0.019, P = 0.001, P = 0.017, and P = 0.029, respectively). Multivariate analysis identified primary surgery as the only independent prognostic factor for disease-free survival (P = 0.026). Cavernous sinus invasion by sinonasal adenoid cystic carcinoma was not associated with worse overall survival or disease-free survival (P = 0.200 and P = 0.198, respectively). CONCLUSIONS: Because maxillary adenoid cystic carcinoma is associated with a higher rate of cavernous sinus invasion, such cases warrant caution during preoperative planning. Primary surgery as the initial therapy provides better locoregional control and survival for patients with sinonasal adenoid cystic carcinoma. Cavernous sinus invasion did not significantly impact survival; thus, it should not be regarded as a contraindication for curative treatment. BioMed Central 2018-02-05 /pmc/articles/PMC5800036/ /pubmed/29402308 http://dx.doi.org/10.1186/s40463-018-0257-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
Lee, Yi-Chan
Lee, Ta-Jen
Tsang, Ngan-Ming
Huang, Yenlin
Hsu, Cheng-Lung
Hsin, Li-Jen
Lee, Yi-Hsuan
Chang, Kai-Ping
Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma
title Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma
title_full Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma
title_fullStr Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma
title_full_unstemmed Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma
title_short Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma
title_sort cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of sinonasal adenoid cystic carcinoma
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800036/
https://www.ncbi.nlm.nih.gov/pubmed/29402308
http://dx.doi.org/10.1186/s40463-018-0257-z
work_keys_str_mv AT leeyichan cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma
AT leetajen cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma
AT tsangnganming cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma
AT huangyenlin cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma
AT hsuchenglung cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma
AT hsinlijen cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma
AT leeyihsuan cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma
AT changkaiping cavernoussinusinvolvementisnotariskfactorfortheprimarytumorsitetreatmentoutcomeofsinonasaladenoidcysticcarcinoma